Women and Myasthenia Gravis

Area of Science:

• Neurology
• Immunology
• Women's Health

Background:

• Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions.
• Women experience MG differently, with unique presentations, disease courses, and quality of life impacts.
• Existing research and clinical trials often overlook sex-specific differences in MG.

Purpose of the Study:

• To review current knowledge on gender-related pathophysiological mechanisms in MG.
• To examine sex-specific clinical phenotypes and management strategies, particularly during reproductive years.
• To highlight the need for gender-stratified research and improved clinical care for women with MG.

Main Methods:

• Narrative review of existing literature on sex differences in MG.
• Synthesis of data on immune reactivity, hormonal influences, and thymic pathology.
• Analysis of clinical phenotypes, quality of life, and treatment responses stratified by sex.

Main Results:

• Women with MG report poorer quality of life despite similar disease severity.
• Reproductive health significantly complicates MG management and decision-making.
• Sex-specific differences exist in immune responses, disease progression, and treatment efficacy.

Conclusions:

• Integrating sex-specific considerations into MG care and research is crucial.
• Gender-stratified analyses and pregnancy registries are needed to address evidence gaps.
• Novel therapies offer potential for more targeted and safer treatment paradigms for all individuals with MG.